rs538267691
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_002691.4(POLD1):c.742G>A(p.Val248Ile) variant causes a missense change. The variant allele was found at a frequency of 0.00000931 in 1,611,144 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_002691.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
POLD1 | NM_002691.4 | c.742G>A | p.Val248Ile | missense_variant | Exon 6 of 27 | ENST00000440232.7 | NP_002682.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152272Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000201 AC: 5AN: 248268Hom.: 0 AF XY: 0.00000744 AC XY: 1AN XY: 134484
GnomAD4 exome AF: 0.00000891 AC: 13AN: 1458754Hom.: 0 Cov.: 34 AF XY: 0.0000110 AC XY: 8AN XY: 725140
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152390Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74528
ClinVar
Submissions by phenotype
not provided Uncertain:2
This variant is denoted POLD1 c.742G>A at the cDNA level, p.Val248Ile (V248I) at the protein level, and results in the change of a Valine to an Isoleucine (GTC>ATC). This variant has not, to our knowledge, been published in the literature as pathogenic or benign. POLD1 Val248Ile was not observed at a significant allele frequency in the NHLBI Exome Sequencing Project. Since Valine and Isoleucine share similar properties, this is considered a conservative amino acid substitution. POLD1 Val248Ile occurs at a position where amino acids with properties similar to Valine are tolerated across species and is not located in a known functional domain (Tahirov 2009, Preston 2010). In silico analyses are inconsistent regarding the effect this variant may have on protein structure and function. Based on currently available evidence, it is unclear whether POLD1 Val248Ile is a pathogenic or benign variant. We consider it to be a variant of uncertain significance. -
- -
Colorectal cancer, susceptibility to, 10 Uncertain:1
This sequence change replaces valine, which is neutral and non-polar, with isoleucine, which is neutral and non-polar, at codon 248 of the POLD1 protein (p.Val248Ile). This variant is present in population databases (rs538267691, gnomAD 0.007%). This variant has not been reported in the literature in individuals affected with POLD1-related conditions. ClinVar contains an entry for this variant (Variation ID: 408099). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt POLD1 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at